Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Cost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Consolidated Net Income (2016 - 2025)

Historic Consolidated Net Income for Lifecore Biomedical, Inc. \De\ (LFCR) over the last 16 years, with Q2 2024 value amounting to $3000.0.

  • Lifecore Biomedical, Inc. \De\'s Consolidated Net Income rose 10013.12% to $3000.0 in Q2 2024 from the same period last year, while for Feb 2025 it was $3000.0, marking a year-over-year decrease of 9923.66%. This contributed to the annual value of $2.7 million for FY2024, which is 10759.19% up from last year.
  • Lifecore Biomedical, Inc. \De\'s Consolidated Net Income amounted to $3000.0 in Q2 2024, which was up 10013.12% from $847000.0 recorded in Q1 2024.
  • Over the past 5 years, Lifecore Biomedical, Inc. \De\'s Consolidated Net Income peaked at $1.9 million during Q3 2023, and registered a low of -$51.6 million during Q2 2022.
  • For the 5-year period, Lifecore Biomedical, Inc. \De\'s Consolidated Net Income averaged around -$10.2 million, with its median value being -$3.6 million (2022).
  • In the last 5 years, Lifecore Biomedical, Inc. \De\'s Consolidated Net Income crashed by 241057.11% in 2020 and then surged by 14357.83% in 2023.
  • Lifecore Biomedical, Inc. \De\'s Consolidated Net Income (Quarter) stood at -$4.0 million in 2020, then plummeted by 1039.91% to -$46.0 million in 2021, then skyrocketed by 92.17% to -$3.6 million in 2022, then soared by 99.33% to -$24000.0 in 2023, then skyrocketed by 112.5% to $3000.0 in 2024.
  • Its Consolidated Net Income stands at $3000.0 for Q2 2024, versus $847000.0 for Q1 2024 and -$24000.0 for Q4 2023.